Mumbai, May 14 (IANS) Ameera Shah-led diagnostics chain Metropolis Healthcare has reported a 19.96 per cent drop in its consolidated net profit for the fourth quarter of the financial year (Q4 FY25), as expenses shot up in the period.
The company’s net profit declined to Rs 29.23 crore in January-March quarter from Rs 36.52 crore in the same period last year (Q4 FY24), according to its filing with the stock exchanges.
The fall in profit came despite a rise in revenue. The diagnostics chain posted a 4.13 per cent increase in revenue from operations, which stood at Rs 345.29 crore in Q4, compared to Rs 331 crore in the year-ago quarter.
However, higher operating costs weighed on the bottom line. Total expenses during the quarter rose by 11.74 per cent year-on-year (YoY), reaching Rs 316.21 crore, up from Rs 283 crore in the corresponding quarter last fiscal.
Among the key cost components, the cost of materials consumed increased by 6.62 per cent to Rs 71.53 crore, while employee benefits expense jumped 15.01 per cent to Rs 82.19 crore from Rs 71.46 crore in the same quarter last fiscal.
The increase in expenses outpaced revenue growth, putting pressure on the company’s profitability in the March quarter.
However, for the full fiscal year 2025 (FY25), Metropolis Healthcare reported a net profit of Rs 146 crore, marking a rise from Rs 128 crore in FY24.
Despite the dip in quarterly profit, Metropolis remains optimistic about its long-term growth strategy.
Shah, as Chairperson and Whole-time Director of the company, emphasised the company’s resilience and future readiness, stating, “Metropolis has been actively investing in expanding its network of laboratories, technology, and talent.”
She added that despite a challenging environment, the company has seen significant improvements in customer engagement and operational efficiency.
“Metropolis is also focusing on expanding its B2C presence, which it believes will contribute significantly to its next phase of growth,” Shah mentioned.
Meanwhile, the shares of Metropolis Healthcare were trading 4.95 per cent or Rs 84.2 lower at Rs 1,617.40 on the National Stock Exchange (NSE) on Tuesday.
–IANS
pk/na
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
